Should We Use Gene Editing to Create Super Babies?
By Katie Hasson,
The New York Times Upfront
| 02. 17. 2025
A young couple wants to have a baby, but they’re worried it’ll carry a disease that runs in the family. “There’s a solution,” the doctor says, “a technology that can alter the disease-causing gene in the egg, ensuring that the baby is born healthy.”
“How about giving our child blue eyes and musical talent?” the parents ask. “I think I can help you,” the doctor says.
Such a conversation once belonged only in the realm of science fiction. But with advances in gene-editing technologies such as CRISPR, fiction might become reality. In 2018, a doctor in China announced that he’d used CRISPR to edit twin girls’ DNA to protect them against the AIDS virus.
But not everyone thinks the world is ready for all the implications of tinkering with human genes. For instance, who’d get to decide which traits should be changed? And aren’t the traits we’re born with part of who we are? In a recent Pew Research Center study, about half of Americans agreed that it was “meddling with nature” and “a line we should...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...